We are evaluating the safety and tolerability of TB0010 in patients with head and neck squamous cell carcinoma. This study aims to understand how the drug is distributed in the body.
Health conditions and diseases that the clinical trial is designed to study and treat.
EGFR-Positive Head and Neck Squamous Cell Carcinoma is a type of cancer that occurs in the head and neck region, characterized by the presence of the epidermal growth factor receptor (EGFR), which can affect treatment options and prognosis.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.